Washington, D.C., (December 4, 2018) —MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD. Read more.
Recent Posts
- Walking & Running Forward for Research
Mark your calendars now to connect with other MHRI and MedStar associates by participating in one of... - Honoring SPIRIT at MHRI: The Ryan White Team
The Ryan White Team was awarded the SPIRIT of Excellence Award for the first quarter of 2019 during ... - Cardiovascular Research Technologies (CRT) Conference 2020—February 22-25, 2020
Join more than 3,000 interventional and endovascular specialists at Cardiovascular Research Technol...
Contact
Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected]